Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:30:53 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 10.46 CHF | -2.79% |
|
-6.10% | -56.14% |
| Market Cap | 235M 268M 222M 202M 379M 25.67B 381M 2.66B 1.03B 13.11B 1.01B 984M 42.13B | P/E 2026 * |
-8.49x | P/E 2027 * | 316x |
|---|---|---|---|---|---|
| Enterprise Value | 249M 284M 235M 214M 402M 27.22B 404M 2.82B 1.09B 13.9B 1.07B 1.04B 44.68B | EV / Sales 2026 * |
29.4x | EV / Sales 2027 * | 6.36x |
| Free-Float |
87.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NWRN | Delayed | |
Tradegate
| NP5 | Real-time | |
|
Xetra
| NP5 | Delayed | |
|
Boerse Muenchen
| NP5 | Real-time | |
|
Börse Stuttgart
| NP5 | Delayed | |
|
CBOE
| 0QOI | Real-time | |
|
Deutsche Boerse AG
| NP5 | Delayed |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | -2.79% | ||
| 1 week | -6.10% | ||
| Current month | -15.24% | ||
| 1 month | -16.19% | ||
| 3 months | -16.05% | ||
| 6 months | -28.55% | ||
| Current year | -56.14% |
| 1 week | 10.44 |  | 11.56 |
| 1 month | 10.44 | | 12.8 |
| Current year | 10.44 | | 31.85 |
| 1 year | 9.98 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/12/26 | Buy | Chief Executive Officer | 2,000 | 0.0096% | ||
| 8/11/26 | Buy | Chief Technology Officer | 582 | 0.0028% | ||
| 8/10/26 | Buy | Chief Technology Officer | 1,418 | 0.0068% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.79% | -6.10% | -0.38% | +82.23% | 268M | |
| -0.14% | +4.33% | +9.88% | +31.73% | 47.97B | |
| -1.69% | +1.48% | +53.02% | +33.59% | 44.5B | |
| +2.56% | +7.34% | +382.17% | +594.81% | 43.93B | |
| +0.24% | +2.85% | +9.78% | +89.54% | 41.03B | |
| -0.62% | -1.11% | +4.70% | +46.02% | 29.85B | |
| -0.28% | +1.07% | +26.83% | +152.91% | 17.27B | |
| -0.46% | +1.20% | +26.78% | +41.32% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| +3.37% | +9.21% | +9.93% | - | 15.34B | |
| Average | -0.20% | +1.51% | +58.08% | +134.02% | 27.03B | |
| Weighted average by Cap. | +0.10% | +2.86% | +82.95% | +156.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.49M 9.67M 8.01M 7.3M 13.67M 926M 13.76M 95.88M 37.08M 473M 36.3M 35.51M 1.52B | 39.86M 45.4M 37.6M 34.26M 64.21M 4.35B 64.64M 450M 174M 2.22B 170M 167M 7.14B |
| Net income | -29.99M -34.16M -28.29M -25.78M -48.31M -3.27B -48.63M -339M -131M -1.67B -128M -125M -5.37B | -1.96M -2.23M -1.84M -1.68M -3.15M -213M -3.17M -22.1M -8.54M -109M -8.36M -8.18M -350M |
| Net Debt | 14.21M 16.19M 13.4M 12.21M 22.89M 1.55B 23.04M 161M 62.08M 792M 60.77M 59.45M 2.55B | 18.13M 20.65M 17.1M 15.58M 29.2M 1.98B 29.4M 205M 79.21M 1.01B 77.54M 75.85M 3.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | CHF 10.46 | -2.79% | 49,792 |
| 26-09-24 | CHF 10.76 | -4.27% | 32,791 |
| 26-09-23 | CHF 11.24 | +1.63% | 84,406 |
| 26-09-22 | CHF 11.06 | -1.60% | 150,962 |
| 26-09-21 | CHF 11.24 | +0.90% | 43,198 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Select your edition
All financial news and data tailored to specific country editions
